News

 

 

Recently Opened Clinical Trials

Thomas Davis
Associate Professor
Cancer Control

ECOG
Phase II randomized trial of transoral surgical resection followed by low-dose or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer

Marc Ernstoff
Professor
Immunology and Cancer Immunotherapy

Cancer Immunotherapy Trials Network (CITN)
A Phase 1 study of the clinical and immunologic effects of ALT-803, a novel recombinant IL-15 complex in patients with advanced melanoma

Lesley Jarvis
Assistant Professor
Cancer Imaging and Radiobiology

Department Funded
Cherenkov imaging in radiation therapy

Peter Kaufman
Associate Professor
Molecular Therapeutics

Hoffman LaRoche
A randomized, multicenter, open-label, Phase III trial comparing trastuzumab plus pertuzumab plus a taxane following anthracyclines versus trastuzumab emtansine plus pertuzumab following anthracyclines as adjuvant therapy in patients with operable HER2-positive primary breast cancer

Lionel Lewis
Professor
Molecular Therapeutics

Molecular Therapeutics
A dose-finding Phase Ib multicenter study of imatinib in combination with the oral Phosphatidyl-Inositol 3-Kinase (PI3K) inhibitor BYL719 in patients with Gastrointestinal Stromal Tumor (GIST) who failed prior therapy with imatinib and sunitinib